IDEXX Q3 diluted EPS rises 18% to $4.01; Q3 revenue climbs 10% to $1.21 billion

PUBT · 6d ago
IDEXX Q3 diluted EPS rises 18% to $4.01; Q3 revenue climbs 10% to $1.21 billion
  • IDEXX Laboratories’ Q3 2026 diluted earnings per share rose 18% year over year to $4.01.
  • Revenue climbed 10% year over year to $1.21 billion.
  • The company raised its 2026 earnings per share outlook to $14.96–$15.16.
  • Full-year revenue guidance increased to $4.74 billion–$4.77 billion, supported by strong commercial performance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEXX Laboratories Inc. published the original content used to generate this news brief on November 02, 2026, and is solely responsible for the information contained therein.